Liquids & Semisolids

What Makes a Great Liquid Oral Dose CDMO?

Rob Terry

TriRx Pharmaceutical Services

Pathfinder

Offshoring vs. Reshoring vs. Half-Shoring: Which Manufacturing Strategy Is Best for Pharma?

Pharma's Almanac

Tech Transfer

Why Successful Scale-Up and Transfer Capabilities Increasingly Determine Outsourcing Success

Pharma's Almanac

Organoids

Building Bioreactors for Living Architecture: The Manufacturing Challenge for Clinical-Grade Organoids

David Alvaro, Ph.D.

Pharma's Almanac

Cell-Free Synthesis

Cell-Free Biomanufacturing and the Future of Flexible Biologics Production

David Alvaro, Ph.D.

Pharma's Almanac

Peptides

Enabling the Commercialization of Peptide Therapeutics with Manufacturing Advances

Cynthia A. Challener, Ph.D.

Pharma's Almanac

AI in Manufacturing

Validating and Governing AI in GMP Manufacturing

Pharma's Almanac

AI Data Integrity

Data Integrity in the Age of AI-Assisted Manufacturing

Pharma's Almanac

Continuous VV

The Stepwise Future of Continuous Viral Vector Manufacturing

David Alvaro, Ph.D.

Pharma's Almanac

Self-Healing

Beyond Cleaning: Could Self-Healing Materials Redefine Bioprocess Surfaces?

David Alvaro, Ph.D.

Pharma's Almanac

Psychedelics CMC

The CMC Challenge for Psychedelic Drugs

David Alvaro, Ph.D.

Pharma's Almanac

Peptide Production

Peptide Manufacturing Enters the Industrial Era

David Alvaro, Ph.D.

Pharma's Almanac

Greener TIDES

Greener Pathways for Peptide and Oligonucleotide Manufacturing

David Alvaro, Ph.D.

Pharma's Almanac

ADC Platform

From mAbs to ADCs: Rethinking the Platform Manufacturing Model

David Alvaro, Ph.D.

Pharma's Almanac

Pathfinder

Single-Use vs. Stainless-Steel Bioreactors: Which Manufacturing Platform Is Better for Biopharmaceutical Production?

Pharma's Almanac

Sustainable CIP

Sustainable Clean-in-Place: Rethinking Legacy Chemistry in Modern Biomanufacturing

David Alvaro, Ph.D.

Pharma's Almanac

Scaling Oligos

Scaling Oligonucleotide Manufacturing: When Chemistry Becomes the Constraint

David Alvaro, Ph.D.

Pharma's Almanac

On-Demand Mfg

Pharmacy on Demand: Can Medicines Be Manufactured at the Point of Need?

David Alvaro, Ph.D.

Pharma's Almanac

Conjugate Payloads

Beyond Cytotoxins: Expanding the Payload Landscape for Antibody-Based Conjugates

David Alvaro, Ph.D.

Pharma's Almanac

Carbon Footprint

Product Carbon Footprint: Enabling Product-Level Decarbonization in Biopharma

Jimin Han

Samsung Biologics